[Respiratory and renal insufficiency in a COPD patient receiving corticoid treatment].
Tirado
María Dolores
MD
Servicio de Microbiología. Hospital General de Castellón. España.
Gil
María
M
Galiano
José
J
Pardo
Francisco
F
Moreno
Rosario
R
Del Busto
Alfonso G
AG
Sabater
Susana
S
Gomila
Bárbara
B
D058186:Acute Kidney Injury / Q000209:etiology*; D000368:Aged; D000818:Animals; D003422:Critical Care; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003967:Diarrhea / Q000209:etiology; D004198:Disease Susceptibility; D005076:Exanthema / Q000209:etiology; D017809:Fatal Outcome; D006331:Heart Diseases / Q000150:complications; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007411:Intestinal Diseases, Parasitic / Q000150:complications* / Q000469:parasitology; D007814:Larva; D008297:Male; D008775:Methylprednisolone / Q000009:adverse effects* / Q000627:therapeutic use; D018410:Pneumonia, Bacterial / Q000150:complications; D011552:Pseudomonas Infections / Q000150:complications; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications* / Q000188:drug therapy; D012131:Respiratory Insufficiency / Q000209:etiology*; D016868:Serratia Infections / Q000150:complications; D012706:Serratia marcescens / Q000302:isolation & purification; D017171:Strongyloides stercoralis / Q000254:growth & development / Q000302:isolation & purification*; D013322:Strongyloidiasis / Q000150:complications* / Q000469:parasitology
D007166:Immunosuppressive Agents; D008775:Methylprednisolone